Guardant Health, Inc. September 16, 2018Board of Directors Offer Letter • November 19th, 2018 • Guardant Health, Inc. • Services-medical laboratories
Contract Type FiledNovember 19th, 2018 Company IndustryThis offer letter (this “Amended Letter”) amends and restates the offer letter between you and Guardant Health, Inc. (the “Company”), dated November 30, 2016 (the “Offer Letter”), in its entirety and will provide the terms under which you will continue to serve as a member of the Board of Directors (the “Board”) of the Company from and after the closing of the initial public offering of the Company’s common stock (the “IPO”).
Guardant Health, Inc. September 16, 2018Board of Directors Agreement • November 19th, 2018 • Guardant Health, Inc. • Services-medical laboratories
Contract Type FiledNovember 19th, 2018 Company IndustryThis offer letter (this “Amended Letter”) amends and restates the offer letter between you and Guardant Health, Inc. (the “Company”), dated April 6, 2018 (the “Offer Letter”), in its entirety and will provide the terms under which you will continue to serve as a member of the Board of Directors (the “Board”) of the Company from and after the closing of the initial public offering of the Company’s common stock (the “IPO”).